Healthtech Days #3 2022
![](https://trinational-healthtechdays.com/wp-content/uploads/2022/05/HTD_Logo-ashtag-3-grand-format.png)
Market Access Strategy for BIOTECH, MEDTECH and DIGITAL HEALTH STARTUPS
FRANCE GERMANY SWITZERLAND
OCTOBER 20 – 21, 2022
BASEL + ONLINE
Key figures of Trinational HealthTech Days #2:
Individual meetings between startups & investors/corporates
Persons participated to the conferences
Startups (France, Germany, Switzerland) participated to the event
Corporates and investors involved in one-on-one meetings
PROGRAM
20th October Day 1
Market access strategy for health products and country particularities
Basel
10.30 – Doors open, registration, coffee
11.00 – Opening remarks & Intro to Tri-National Healthech Days
Speakers: Christian E. Schneider, Head of the Innovation Office, University of Basel ; Bodo Brückner, Startup Advisor
Coordinator Life Science Accelerator Baden-Wuerttemberg ; Malaika Lauk, Managing Director, BadenCampus ; Guillaume Vetter-Genoud, Head of health department, SEMIA/Quest for change
11.15 – 12.15 – Session 1: The Upper Rhine Life Science Innovation Ecosystem – Leading in Europe
- Keynote: A tri-national startup success story
Speaker: Simon Ittig, CEO & Co-Founder, T3 Pharmaceuticals
-
- Panel discussion: The best place to do life science innovation in Europe
Moderator: Felix Früh, Entrepreneur, investor
Speakers: Jean-Luc Dimarcq, Managing Director, IHU Strasbourg ; Gabriela Güntherodt, Director, Biotech Sector Lead, Switzerland, EY ; Philipp Marchand, Managing Director, Vossius & Partner
- Panel discussion: The best place to do life science innovation in Europe
13.30 – 15.00 – Session 2: Collaboration with industry – invest (growth of startup)
- Session A (for medtech startups) – On the journey with MedTech entrepreneurs: pitfalls, learnings and what does it take to be successful
Moderator: Angélie Pham, Innovation Office University of Basel
Speakers: Elmar Zurbriggen, CEO, AOT ; Tobias Wilken, CPO, AOT ; Melanie Schäpers, COO, Sefunda ; Christian Zwicky, Deep Breath Intelligence
- Session B (for biotech startups) – Dealing with BigPharma or VC from a start-up perspective – When and how? Discussion around hidden challenges, risks and key success factors for a proper partnering readiness – in partnership with Swiss HLG
Moderator: Zaki Sellam, Serial biotech entrepreneur, Swiss HLG start-up initiative
Speakers: Sarah Holland, President of Swiss HLG ; Samantha Brandler, Head of Research Innovation Europe, CSL Behring ; Sara Nunez-Garcia, Co-Founder, Forty51 Ventures, Michael Huebner, Director Early Innovation Partnering, Johnson & Johnson Innovation
- Session C (for digital health startups) – The digital transition: How startups can help established corporations and established corporations help startups?
Speakers: Greg Nelson, Project Manager Aesculap M&A/external Innovation, Innovation Hub, B. Braun ; Murat Akturk, Global Growth Director, Edison for Enterprise, GE HealthCare ; Christoph Wagner, CEO WBG Holding & Karsten Sternberg, Senior Advisor Medipee ; Bastian Deck, CEO & Founder NOVAZOON & Steffen Bäumler, CPO MAEX
15.00 – 15.15 – Closing, learnings & Call to Action
15.15 – 17.00 – Networking & Apero
21th October – Day 2
One-on-One meetings of startups and investors/corporates
Online
13.00 – 13.15 : Opening & Instructions
13.15 – 16.00 : One-on-One sessions